Innolith makes breakthrough in vehicle batteries
Energy company Innolith has developed a new type of battery that gives electric vehicles a range of 1,000km. The innovation has now been registered for a patent and will be launched on the market via an initial pilot production.
Basel energy company Innolith has developed a battery innovation at its German laboratory in Bruchsal. According to a press release, this rechargeable battery is capable of powering an electric vehicle for over 1,000km on a single charge. The battery avoids exotic and expensive materials and therefore radically reduces overall cost.
In addition to its range and cost advantages, the new battery is also safer. It is the first non-flammable lithium-based battery for use in electric vehicles. Rather than conventional flammable organic electrolytes, the Innolith battery uses a non-flammable inorganic electrolyte.
A patent application has been filed for this battery technology and Innolith is maintaining commercial confidentiality on the cell chemistry mechanism. The chemistry used in this battery has reportedly been proven to operate for more than 55,000 full depth discharge cycles, which is between 10 and 100 times the maximum number of cycles of existing lithium ion batteries in use today.
Innolith will be bringing its Energy Battery to market via an initial pilot production in Germany soon. The aim is to later conclude licensing partnerships with battery manufacturers. BaselArea.swiss supported Innolith in 2018 with the opening of the global headquarters in Basel.
Share this article
You might also be interested in
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.Read More
Two institutes from the University of Basel and a pharmaceutical company are relocating to the GRID innovation and enterprise campus, which is currently under construction at BaseLink in Allschwil. The new building will also contain the headquarters of the Switzerland Innovation Park Basel Area in future.Read More
Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.Read More
The American health authority has granted Polyneuron’s drug PN-1007 orphan designation. This status uses special conditions to balance out commercial disadvantages when developing drugs for rare diseases.Read More